Atlanta, GANCT07115004Now EnrollingIRB Ready

Von Willebrand Disease (VWD) Clinical Trial in Atlanta, GA

Access cutting-edge von willebrand disease (vwd) treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.

Sponsored by Vega Therapeutics, Inc

Quick Self-Assessment

See if you qualify for this Atlanta location

Preparing your pre-screening questions…

Expert Care in Atlanta

Access von willebrand disease (vwd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related von willebrand disease (vwd) treatment provided free

Apply for This Atlanta Location

Check if you qualify for this von willebrand disease (vwd) clinical trial in Atlanta, GA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Atlanta

    Convenient for GA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Atlanta site if eligible
  4. 4Begin participation

About This Von Willebrand Disease (VWD) Study in Atlanta

This is a phase 3 study that will evaluate subcutaneous (SC) VGA039 in patients with von Willebrand Disease (VWD)

Sponsor: Vega Therapeutics, Inc

Who Can Participate

Inclusion Criteria

12 to 75 years of age, inclusive
No clinically significant laboratory, ECG, or vital signs results
Documented diagnosis consistent with VWD of any type
Historical annualized bleeding rate (ABR; excluding menstrual bleeds and bleeds under the skin) of both untreated and treated bleeds ≥12 per year
Patients with VWD who are judged by the investigator to be suitable candidates for routine prophylaxis to reduce the frequency of bleeding episodes
Hemoglobin level ≥ 8 g/dL and platelet count ≥ 100 x 109/L at Screening Key

Exclusion Criteria

Use of routine prophylaxis of VWF-containing concentrates defined as at least 1 VWF-containing concentrate infusion to prevent or reduce bleeding per week during the previous 6 months prior to screening
Planning to initiate routine prophylaxis with VWF-containing concentrates or any other hemostatic treatment during the study
Patients with pro-thrombotic disorders or abnormal findings on laboratory thrombophilia evaluation performed at screening or previously documented
History of arterial or venous thrombosis, including superficial thrombophlebitis, or embolism
Evidence of renal, hepatic, central nervous system, respiratory, cardiovascular disease, cerebrovascular disease, peripheral vascular disease, or metabolic dysfunction
Baseline FVIII activity \> lower limit of normal (LLN)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Atlanta?

Yes, this clinical trial (NCT07115004) has an active research site in Atlanta, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Von Willebrand Disease (VWD) Treatment Options in Atlanta, GA

If you're searching for von willebrand disease (vwd) treatment options in Atlanta, GA, this clinical trial (NCT07115004) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced von willebrand disease (vwd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all von willebrand disease (vwd) clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Atlanta, GA

See all rheumatoid arthritis clinical trials recruiting in Atlanta — not just this study.

Browse Rheumatoid Arthritis Trials in Atlanta →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsVon Willebrand Disease TrialsAll Conditions →

Ready to Join in Atlanta?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Atlanta, GA